USFDA Approves Higher-Dose Wegovy to Boost Weight Loss Outcomes sheeba farhat21 March 2026 11:00 AM ISTWashington: Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users lose more...
Eli Lilly to Invest USD 3 Billion in China to Boost Production of Diabetes, Obesity Drug Orforglipron sheeba farhat12 March 2026 10:00 AM ISTShanghai: Eli Lilly plans to invest USD 3 billion over the next decade to expand supply chain capacity in China and build production capacity for its...
Weight Regain Common After Stopping Weight Management Medications: Meta-Analysis Finds Aashi verma18 Feb 2026 9:15 PM ISTUK: A recent systematic review and meta-analysis reveals that discontinuing weight management medications (WMMs) leads to an average monthly weight...
Natco Pharma Gets Court Nod to Make, Export Semaglutide for Diabetes and Obesity Markets Susmita Roy10 Feb 2026 7:32 PM ISTNew Delhi: Natco Pharma has secured regulatory clearance from the High Court to manufacture semaglutide and export the drug to select international...
Emcure Beats 9 Rivals to Secure Second Semaglutide Brand from Novo Nordisk for India Parthika Patel5 Feb 2026 10:31 PM ISTNew Delhi: Emcure Pharmaceuticals has secured exclusive rights to market a second brand of semaglutide in India through a partnership with Novo...
Roche's Experimental Obesity Drug Delivers Up to 22.5% Weight Loss in Phase-II Trial sheeba farhat28 Jan 2026 4:46 PM ISTRoche's experimental obesity drug CT-388 reduces appetite and is in the same class as Lilly's market-leading Zepbound, also known as tirzepatide and...
Cipla Emerges as Domestic Contender in Anti-Obesity Market with Yurpeak Susmita Roy10 Jan 2026 10:06 PM ISTNew Delhi: India's third-largest drugmaker Cipla has made an early impact in the fast-expanding anti-obesity drug market, with its GLP-1 agonist brand...
Natco Pharma Challenges Novo Nordisk's Wegovy Patent, Reaches Delhi High Court Susmita Roy7 Jan 2026 11:19 PM ISTNew Delhi: Hyderabad-based Natco Pharma has approached the Delhi High Court with a petition seeking revocation of a patent held by Novo Nordisk, the...
Sun Pharma says obesity drugs to be new growth driver for pharma industry Ruchika Sharma29 Dec 2025 3:30 PM ISTNew Delhi: Expanding access to GLP-1 therapies over the coming years will be a major driver for India’s pharmaceutical industry, helping tackle...
Use weight reducing drugs judiciously: Dr Jitendra Singh Ruchika Sharma20 Dec 2025 7:37 PM ISTNew Delhi: Union Minister of State (Independent Charge) for Science & Technology, Dr Jitendra Singh, has said that weight reducing or anti-obesity...
Eli Lilly's Diabetes Drug Mounjaro Gets Second Brand Yurpeak via Cipla Deal Farhat Nasim24 Oct 2025 11:36 AM ISTNew Delhi: In a move aimed at expanding access to obesity and diabetes care in India, Eli Lilly and Company (India) Pvt. Ltd. (Lilly) and Cipla...
Post WHO alert, Novo Nordisk seeks EMA nod for higher dose of obesity treatment Wegovy Ruchika Sharma9 July 2025 11:36 AM ISTDenmark: Following a recent World Health Organization (WHO) alert on semaglutide-containing medicines, Novo Nordisk has announced the...
